Budesonide Orodispersible Tablets are Highly Effective for Treatment of Active Eosinophilic Esophagitis: Results from a Randomized, Double-Blind, Placebo-Controlled, Pivotal Multicenter Trial (EOS-1)
Year: 2017
Type: article
Source: Gastroenterology
Authors: Alfredo Lucendo, Stephan Miehlke, Michael Vieth, Christoph Schlag, Ulrike Von Arnim, Javier Molina-Infante, Dirk Hartmann, Albert J. Bredenoord, Constanza Ciriza De Los Ríos, Stefan Schubert, Stefan Brückner, Ahmed Madisch, Jamal O. Hayat, Jan F. Tack, Stephen E. Attwood, Ralph Mueller, Roland Greinwald, Alain M. Schoepfer, Alex Straumann
Language: English
Topic: Eosinophilic Esophagitis
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keywords: eosinophilic esophagitis, budesonide, orally disintegrating tablets, FODMAPs, low FODMAP diet, functional gastrointestinal disorders, lactose intolerance, fructose intolerance, irritable bowel syndrome, functional dyspepsia, symptom relief, predictors of treatment response, Rome III criteria, pruritus, nausea, diarrhea, breath test, dietary intervention
Open Access status: closed
OpenAlex ID: W2606567331
